Torrent Pharmaceuticals Limited

Quick facts

Phase 3 pipeline

• TRC150094 · Metabolic/Endocrinology
  TRC150094 is a selective peroxisome proliferator-activated receptor delta (PPARδ) agonist that enhances insulin sensitivity and lipid metabolism.

Phase 1 pipeline

• Daiichi Sankyo Inc's Benicar Tablets 40 mg
• Escitalopram Oxalate Tablets
• Forest Pharmaceuticals Inc's Bystolic Tablets
• Losartan Potassium and Hydrochlorothiazide Tablets
• Torrent's Donepezil Hydrochloride Tablets 10mg
• Torrent's Felodipine Extended-Release Tablets
• Torrent's Fluoxetine Tablets
• Torrent's Nebivolol Tablets
• Torrent's Pioglitazone
• Torrent's Quetiapine Fumarate Tablets
• Tribenzor of Daichi Sankyo Inc. USA
• Warner Chilcott LLC's Sarafem Tablet
• Warner Chilcott LLC Sarafem Tablets

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Torrent Pharmaceuticals Limited portfolio CI brief
• Torrent Pharmaceuticals Limited pipeline updates RSS